Among the several mechanisms proposed in attributing the ability of PPARγ ligand in inhibiting leiomyoma cell growth, Houston suggested that the inhibition was mediated by negative cross-talk between ER and PPAR signaling pathway where the activation of PPARγ inhibits ER-mediated gene expression (Houston et al., 2003). Here, PPARG is linked to leiomyoma.